These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 20035905)
1. Magnesium hydroxide temporarily enhancing osteoblast activity and decreasing the osteoclast number in peri-implant bone remodelling. Janning C; Willbold E; Vogt C; Nellesen J; Meyer-Lindenberg A; Windhagen H; Thorey F; Witte F Acta Biomater; 2010 May; 6(5):1861-8. PubMed ID: 20035905 [TBL] [Abstract][Full Text] [Related]
2. Biocompatibility of rapidly solidified magnesium alloy RS66 as a temporary biodegradable metal. Willbold E; Kalla K; Bartsch I; Bobe K; Brauneis M; Remennik S; Shechtman D; Nellesen J; Tillmann W; Vogt C; Witte F Acta Biomater; 2013 Nov; 9(10):8509-17. PubMed ID: 23416472 [TBL] [Abstract][Full Text] [Related]
3. In vivo corrosion of four magnesium alloys and the associated bone response. Witte F; Kaese V; Haferkamp H; Switzer E; Meyer-Lindenberg A; Wirth CJ; Windhagen H Biomaterials; 2005 Jun; 26(17):3557-63. PubMed ID: 15621246 [TBL] [Abstract][Full Text] [Related]
4. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity. Lossdörfer S; Schwartz Z; Wang L; Lohmann CH; Turner JD; Wieland M; Cochran DL; Boyan BD J Biomed Mater Res A; 2004 Sep; 70(3):361-9. PubMed ID: 15293309 [TBL] [Abstract][Full Text] [Related]
5. Enhanced bone ingrowth into hydroxyapatite with interconnected pores by Electrical Polarization. Itoh S; Nakamura S; Nakamura M; Shinomiya K; Yamashita K Biomaterials; 2006 Nov; 27(32):5572-9. PubMed ID: 16876861 [TBL] [Abstract][Full Text] [Related]
6. Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy. Murakami H; Nakamura T; Tsurukami H; Abe M; Barbier A; Suzuki K J Bone Miner Res; 1994 Sep; 9(9):1355-64. PubMed ID: 7529459 [TBL] [Abstract][Full Text] [Related]
7. Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate. Tanaka T; Saito M; Chazono M; Kumagae Y; Kikuchi T; Kitasato S; Marumo K J Biomed Mater Res A; 2010 May; 93(2):469-74. PubMed ID: 19582838 [TBL] [Abstract][Full Text] [Related]
8. Climbing exercise increases bone mass and trabecular bone turnover through transient regulation of marrow osteogenic and osteoclastogenic potentials in mice. Mori T; Okimoto N; Sakai A; Okazaki Y; Nakura N; Notomi T; Nakamura T J Bone Miner Res; 2003 Nov; 18(11):2002-9. PubMed ID: 14606513 [TBL] [Abstract][Full Text] [Related]
9. In vivo corrosion and corrosion protection of magnesium alloy LAE442. Witte F; Fischer J; Nellesen J; Vogt C; Vogt J; Donath T; Beckmann F Acta Biomater; 2010 May; 6(5):1792-9. PubMed ID: 19822226 [TBL] [Abstract][Full Text] [Related]
10. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation. Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673 [TBL] [Abstract][Full Text] [Related]
11. [Bone histology in postmenopausal osteoporosis--variations in cellular activity]. Lozo P; Krpan D; Krvavica A; Vukelić Baturić T; Fistonić I; Kusec V Acta Med Croatica; 2004; 58(1):5-11. PubMed ID: 15125387 [TBL] [Abstract][Full Text] [Related]
12. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats. Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644 [TBL] [Abstract][Full Text] [Related]
13. Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption. Rude RK; Kirchen ME; Gruber HE; Meyer MH; Luck JS; Crawford DL Magnes Res; 1999 Dec; 12(4):257-67. PubMed ID: 10612083 [TBL] [Abstract][Full Text] [Related]
14. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. Koyama H; Nakade O; Takada Y; Kaku T; Lau KH J Bone Miner Res; 2002 Jul; 17(7):1219-29. PubMed ID: 12096835 [TBL] [Abstract][Full Text] [Related]
15. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity. Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311 [TBL] [Abstract][Full Text] [Related]
17. The development of binary Mg-Ca alloys for use as biodegradable materials within bone. Li Z; Gu X; Lou S; Zheng Y Biomaterials; 2008 Apr; 29(10):1329-44. PubMed ID: 18191191 [TBL] [Abstract][Full Text] [Related]
18. Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patients. Tsangari H; Findlay DM; Zannettino AC; Pan B; Kuliwaba JS; Fazzalari NL Bone; 2006 Dec; 39(6):1226-35. PubMed ID: 16926124 [TBL] [Abstract][Full Text] [Related]
19. Studies of bone tissue in rats treated by prednisolone and 1,25-(OH)2D3. Lindgren JU; Johnell O; DeLuca HF Clin Orthop Relat Res; 1983 Dec; (181):264-8. PubMed ID: 6688979 [TBL] [Abstract][Full Text] [Related]
20. Long-term in vivo degradation behaviour and biocompatibility of the magnesium alloy ZEK100 for use as a biodegradable bone implant. Dziuba D; Meyer-Lindenberg A; Seitz JM; Waizy H; Angrisani N; Reifenrath J Acta Biomater; 2013 Nov; 9(10):8548-60. PubMed ID: 22922249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]